CorVel Corp. 10-Q Summary: Quarter Ended June 30, 2004
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for CorVel Corporation, an independent nationwide provider of medical cost containment and managed care services for workers' compensation and auto policies. The report covers the three-month period ended June 30, 2004. The company operates in a single reportable segment: managed care.
Key Financial Metrics
| Metric | Q2 2004 | Q2 2003 |
|---|---|---|
| Revenues | $76.3 million | $75.9 million |
| Gross Profit | $12.9 million | $13.6 million |
| Gross Margin | 16.9% | 17.9% |
| Net Income | $3.4 million | $4.4 million |
| Diluted EPS | $0.32 | $0.40 |
| Operating Cash Flow | $8.8 million | $9.0 million |
| Cash and Equivalents | $12.3 million | $5.5 million (end of Q2 2003) |
| Total Debt | $0 | $0 |
The company maintains a $5 million line of credit with no outstanding borrowings as of June 30, 2004.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased slightly by 0.5% ($0.4 million) year-over-year. However, excluding the impact of the Scan One acquisition, organic revenues would have decreased by 0.5%.
- Profitability Decline: Net income decreased by 21.7% ($0.9 million) to $3.4 million. Operating income dropped 21.1% to $5.5 million.
- Margin Compression: Gross profit margin contracted from 17.9% to 16.9% due to cost of revenue increasing at a faster rate (1.7%) than revenue (0.5%). General and administrative expenses rose 11.9% to $7.4 million, driven by increased systems costs for software implementation.
- Share Repurchases: The company repurchased 76,223 shares for $2.0 million during the quarter. Cumulative repurchases total 5.65 million shares.
Outlook, Risks, and Management Commentary
Management Commentary: Management cites a challenging market environment characterized by declining manufacturing employment, reduced workers' compensation claims volume, and intense price competition. Sequential revenue declined 0.7% from the prior quarter. The company is investing in information systems (CareMC) and data center capabilities, which has increased operating expenses.
Risks and Contingencies:
- Regulatory Changes: Potential legislative reforms in workers' compensation and healthcare laws could reduce demand for the company's services.
- Competition: Increased competition from larger entities and the trend of customers insourcing managed care services.
- Accounting Changes: Future adoption of SFAS 123 (expensing stock options) could materially reduce reported earnings.
- Legal Liability: Exposure to litigation regarding medical treatment recommendations, though management believes current insurance is adequate.
Investor Verification Checklist
- Verify the sustainability of revenue growth given the 0.5% organic decline reported.
- Monitor the trajectory of General and Administrative expenses as a percentage of revenue (currently 9.7%) to ensure margin recovery.
- Assess the impact of the Scan One acquisition on long-term profitability versus short-term integration costs.
- Review the company's ability to maintain its quick ratio covenant (currently >2:1) if operating cash flows weaken.
- Confirm the status of the $5 million credit line and any potential need for additional financing given the capital-intensive nature of system upgrades.